Developer docs
API playgroundTry for free, no card

Search company profiles

Arete Biosciences

Full company profile

uuid0009cy8

Namestring
Arete Biosciences
Legal namestring
Arete Biosciences
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Arete Biosciences is a Carlsbad, California-based multidisciplinary product development firm serving health-tech and life sciences clients. The company operates as an integrated service provider spanning industrial design, mechanical and electrical engineering, clinical operations, quality systems, and regulatory affairs, with in-house infrastructure including BSL-2 laboratories, lyophilization capability, an ISO 13485-certified pilot line, and a biorepository. It also operates clinical data systems aligned to 21 CFR Part 11. Its client base spans diagnostic developers (Alamar Biosciences, Cubit Diagnostics, Exokeryx, PlexBio, Papilio), therapeutics and biologics companies (Boca Biolistics), consumer health firms (Asima Health, LoBio), and larger multinational corporations (Denka, Japan), with 30+ engagements completed over 9+ years of operation by a team of 40+ employees.

Arete's core offering is end-to-end product development — from concept and industrial design through clinical trials, quality systems implementation, and regulatory submission support — packaged under a single engagement model. The firm complements direct service delivery with an equity-linked business unit, Arete Ventures, through which it takes minority positions in selected clients. A partner ecosystem comprising Protoshop, Biopharma Group (BTLLC), ICS, and Crucial Data Solutions extends capability into prototyping, bioprocess, software, and biostatistics. The firm's regulatory familiarity across FDA, IVDR, and EU pathways, together with its vertically integrated facility footprint, positions it as a one-stop development partner for health-tech innovators that lack in-house cross-functional capacity.

Revenue derives from professional services fees (project-based and likely milestone-driven, given regulatory and clinical work) supplemented by equity upside from Arete Ventures portfolio holdings. Go-to-market is primarily direct and referral-driven, augmented by industry conference presence (e.g., ADLM 2026, Booth #1060). Customer mix spans early-stage ventures through established multinationals, with a moderate number of flagship accounts visible in marketing collateral. Arete is privately held and does not disclose financials, funding history, or ownership structure publicly.

Short descriptiontext

Arete Biosciences is a Carlsbad, California-based multidisciplinary health-tech product development firm offering integrated industrial design, clinical, quality, and regulatory services to diagnostic, biologics, and consumer health companies across 30+ engagements.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCarlsbad, United States
HQ citystring
Carlsbad
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device development, diagnostic product development, clinical research services, regulatory affairs consulting, industrial design services
Industry3 codes
PRIMARYBPAHACAM
Innovation, Product & R&D Consulting
SECONDARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Device & Diagnostics Product Development Services
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Professional Services (CRO & Consulting)
TypeProfessional Services
Description

Arete Biosciences generates revenue primarily through fee-for-service professional engagements. Services include assay development, product development, industrial design, clinical operations, quality systems consulting, regulatory strategy, and audit services. Revenue is earned through project-based contracts, retainer arrangements, and consulting engagements — billed on a per-project or time-and-materials basis. The company also offers embedded team augmentation where Arete staff work as an extension of the client's organization.

aretebiosciences.com
2Arete Ventures (Operational Investment)
TypeLicensing Royalties
Description

Arete Ventures provides direct financial investment and in-kind services (business strategy, R&D, management) to early-stage health ventures in exchange for equity or revenue-sharing arrangements. This creates an investment/equity revenue stream alongside service fees, as Arete takes equity stakes in the ventures it incubates and supports.

aretebiosciences.com
3Certified Auditing Services
TypeProfessional Services
Description

The company offers certified quality system auditing services to external clients, providing independent audit reports on QMS compliance against ISO 13485, ISO 14971, 21 CFR 820, MDSAP, and QMSR standards — generating additional service revenue.

aretebiosciences.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Arete Ventures
Description

Operational investor providing direct and in-kind investments, business strategy and resources for commercially successful health ventures.

aretebiosciences.com
Core offering1 text field

Arete Biosciences is a multidisciplinary health technology product development firm that partners with diagnostics, MedTech, and life sciences companies to take products from concept through commercialization. Its core offering comprises four integrated service lines: Product Development (assay, consumable, and medical device engineering), Industrial Design (styling, ergonomics, human factors), Clinical, Quality & Regulatory (CRO services for clinical trials, quality systems, and FDA/IVDR regulatory strategy), and Arete Ventures (operational investment and startup incubation). Service delivery is supported by vertically integrated facilities including BSL-2 labs, lyophilization, prototyping, and an ISO 13485-compliant pilot line.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Developed functional first-generation point-of-care molecular diagnostics system with Cubit Diagnostics from assay concept to integrated platform in 18 months
+4 more records
Product overview1 text field

Arete Biosciences offers end-to-end health tech product development services through four integrated offerings: Product Development (assays, consumables, MedTech and medical device development from bench-top through pilot production), Industrial Design (styling, ergonomics, usability, human factors engineering, and manufacturability), Clinical, Quality & Regulatory (CRO services including clinical trial management, quality system development, and FDA/IVDR regulatory strategy), and Arete Ventures (operational investment and startup incubation for health ventures). The company operates as a multidisciplinary partner that integrates cross-functional teams from concept through commercialization.

Product and service1 record
1Product Development
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2026-07-01
Description

Cubit Diagnostics, a long-standing Arete partner and client, used Arete's ADLM 2026 booth (#1060) to unveil and demo its Omnio multimodal point-of-care diagnostics platform. Arete has worked alongside Cubit since the earliest concept phase, investing seed capital, defining product strategy, and leading development to transform a benchtop assay into a fully integrated point-of-care system. The ADLM booth co-exhibition represents a joint marketing and product showcase partnership.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Protoshop provides rapid prototype injection molding services to Arete's development workflow. Their fast-turnaround, soft-tooled molds and medical-grade precision allow Arete to iterate quickly and test concepts in production-quality plastics, with experience in undercuts, overmolding, and tight tolerances.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

BTLLC (US subsidiary of Biopharma Group with 35 years of experience) offers lyophilisation process development, production, and troubleshooting operating under ISO 9001 & 13485 accreditation. The partnership enables Arete to offer cartridge design, microfluidics, wet chemistry, and lyophilization under one roof, with an open IP model where clients retain full ownership of their materials and data.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based product development and engineering consultancy with deep MedTech and diagnostics practice. Comparable to Arete in offering multidisciplinary product development, including assay, instrumentation, and regulatory strategy for diagnostics clients.

TypeEmerging player
Description

Life sciences tools and diagnostics company with growing services and assay development capabilities. Adjacent rather than direct overlap with Arete, but increasingly relevant as diagnostics developers seek integrated partners for assay and consumable development.

3Bayonet Capital / Bayonet Life Sciences
TypeEmerging player
Description

Boutique life sciences consulting firm offering regulatory, quality, and clinical services to IVD and medical device companies. Partial overlap with Arete's Clinical, Quality & Regulatory practice, though smaller and less vertically integrated.

TypeDirect peer
Description

US-based MedTech product development firm offering integrated design, engineering, and regulatory services for diagnostics and medical device companies. Closely matches Arete's full-lifecycle, cross-functional engagement model.

TypeBroad incumbent
Description

Large global CRO/CDMO offering broad R&D, manufacturing, and regulatory services across biologics, small molecules, and MedTech. Competes with Arete's regulatory and clinical services for enterprise diagnostics clients but at much greater scale and scope.

TypeBroad incumbent
Description

Global testing, laboratory services, and product development firm with diagnostics and MedTech practice areas. Overlaps with Arete's clinical/biorepository and assay development services at greater scale and international reach.

TypeBroad incumbent
Description

Global CRO providing clinical trial, regulatory, and laboratory services to pharma, biotech, and MedTech. Competes with Arete's clinical and regulatory services, especially for larger enterprise programs.

TypeBroad incumbent
Description

Major CRO offering preclinical, clinical, and manufacturing services including diagnostics support. Overlaps with Arete's CRO practice but as part of a much broader portfolio serving large enterprise accounts.

TypeDirect peer
Description

Canadian contract medical device design, development, and manufacturing firm. Directly comparable to Arete's integrated MedTech product development and industrial design services for IVD and diagnostics clients.

TypeDirect peer
Description

Australian MedTech product development and commercial manufacturing firm. Directly comparable integrated services model — design, engineering, regulatory, manufacturing — for diagnostics and medical device clients.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arete Biosciences

Medical Device & Diagnostics Product Development Servicesaretebiosciences.com

Arete Biosciences is a Carlsbad, California-based multidisciplinary health-tech product development firm offering integrated industrial design, clinical, quality, and regulatory services to diagnostic, biologics, and consumer health companies across 30+ engagements.

What Arete Biosciences does

Arete Biosciences is a Carlsbad, California-based multidisciplinary product development firm serving health-tech and life sciences clients. The company operates as an integrated service provider spanning industrial design, mechanical and electrical engineering, clinical operations, quality systems, and regulatory affairs, with in-house infrastructure including BSL-2 laboratories, lyophilization capability, an ISO 13485-certified pilot line, and a biorepository. It also operates clinical data systems aligned to 21 CFR Part 11. Its client base spans diagnostic developers (Alamar Biosciences, Cubit Diagnostics, Exokeryx, PlexBio, Papilio), therapeutics and biologics companies (Boca Biolistics), consumer health firms (Asima Health, LoBio), and larger multinational corporations (Denka, Japan), with 30+ engagements completed over 9+ years of operation by a team of 40+ employees.

Arete's core offering is end-to-end product development — from concept and industrial design through clinical trials, quality systems implementation, and regulatory submission support — packaged under a single engagement model. The firm complements direct service delivery with an equity-linked business unit, Arete Ventures, through which it takes minority positions in selected clients. A partner ecosystem comprising Protoshop, Biopharma Group (BTLLC), ICS, and Crucial Data Solutions extends capability into prototyping, bioprocess, software, and biostatistics. The firm's regulatory familiarity across FDA, IVDR, and EU pathways, together with its vertically integrated facility footprint, positions it as a one-stop development partner for health-tech innovators that lack in-house cross-functional capacity.

Revenue derives from professional services fees (project-based and likely milestone-driven, given regulatory and clinical work) supplemented by equity upside from Arete Ventures portfolio holdings. Go-to-market is primarily direct and referral-driven, augmented by industry conference presence (e.g., ADLM 2026, Booth #1060). Customer mix spans early-stage ventures through established multinationals, with a moderate number of flagship accounts visible in marketing collateral. Arete is privately held and does not disclose financials, funding history, or ownership structure publicly.

Arete Biosciences firmographics

Firmographics
Name
Arete Biosciences
Legal name
Arete Biosciences
Website
https://aretebiosciences.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
Arete Biosciences is a Carlsbad, California-based multidisciplinary health-tech product development firm offering integrated industrial design, clinical, quality, and regulatory services to diagnostic, biologics, and consumer health companies across 30+ engagements.
Ownership category
akta.pro rank

Arete Biosciences industry classification

Industry
Product category
Medical Device & Diagnostics Product Development Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYBPAHACAM
Innovation, Product & R&D Consulting
SECONDARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Medical device development
  • Diagnostic product development
  • Clinical research services
  • Regulatory affairs consulting
  • Industrial design services

Where Arete Biosciences is headquartered

Location

Headquarters

HQ city
Carlsbad
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Arete Biosciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Professional Services (CRO & Consulting): Arete Biosciences generates revenue primarily through fee-for-service professional engagements. Services include assay development, product development, industrial design, clinical operations, quality systems consulting, regulatory strategy, and audit services. Revenue is earned through project-based contracts, retainer arrangements, and consulting engagements — billed on a per-project or time-and-materials basis. The company also offers embedded team augmentation where Arete staff work as an extension of the client's organization.
  2. Arete Ventures (Operational Investment): Arete Ventures provides direct financial investment and in-kind services (business strategy, R&D, management) to early-stage health ventures in exchange for equity or revenue-sharing arrangements. This creates an investment/equity revenue stream alongside service fees, as Arete takes equity stakes in the ventures it incubates and supports.
  3. Certified Auditing Services: The company offers certified quality system auditing services to external clients, providing independent audit reports on QMS compliance against ISO 13485, ISO 14971, 21 CFR 820, MDSAP, and QMSR standards — generating additional service revenue.

Go-to-market motion3 records

Distribution channels1 record

Marketing channels6 records

Arete Biosciences product offering

Product offering

Core offering

Arete Biosciences is a multidisciplinary health technology product development firm that partners with diagnostics, MedTech, and life sciences companies to take products from concept through commercialization. Its core offering comprises four integrated service lines: Product Development (assay, consumable, and medical device engineering), Industrial Design (styling, ergonomics, human factors), Clinical, Quality & Regulatory (CRO services for clinical trials, quality systems, and FDA/IVDR regulatory strategy), and Arete Ventures (operational investment and startup incubation). Service delivery is supported by vertically integrated facilities including BSL-2 labs, lyophilization, prototyping, and an ISO 13485-compliant pilot line.

Product overview

Arete Biosciences offers end-to-end health tech product development services through four integrated offerings: Product Development (assays, consumables, MedTech and medical device development from bench-top through pilot production), Industrial Design (styling, ergonomics, usability, human factors engineering, and manufacturability), Clinical, Quality & Regulatory (CRO services including clinical trial management, quality system development, and FDA/IVDR regulatory strategy), and Arete Ventures (operational investment and startup incubation for health ventures). The company operates as a multidisciplinary partner that integrates cross-functional teams from concept through commercialization.

Differentiator

Problem solved

Functional benefit

Brands

  • Arete Ventures: Operational investor providing direct and in-kind investments, business strategy and resources for commercially successful health ventures.

Products and services

  • Product Development

Quantifiable outcome

  • Developed functional first-generation point-of-care molecular diagnostics system with Cubit Diagnostics from assay concept to integrated platform in 18 months
  • +4 more outcomes

Companies that use Arete Biosciences

Customer profile

Named customers12 records

Segments4 records

Ideal customer profiles4 records

Arete Biosciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Arete Biosciences partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Cubit DiagnosticscoreGTM or Marketing Partner · 1 July 2026Cubit Diagnostics, a long-standing Arete partner and client, used Arete's ADLM 2026 booth (#1060) to unveil and demo its Omnio multimodal point-of-care diagnostics platform. Arete has worked alongside Cubit since the earliest concept phase, investing seed capital, defining product strategy, and leading development to transform a benchtop assay into a fully integrated point-of-care system. The ADLM booth co-exhibition represents a joint marketing and product showcase partnership.
  • ProtoshopminorStrategic or Co-development PartnerProtoshop provides rapid prototype injection molding services to Arete's development workflow. Their fast-turnaround, soft-tooled molds and medical-grade precision allow Arete to iterate quickly and test concepts in production-quality plastics, with experience in undercuts, overmolding, and tight tolerances.
  • Biopharma Group (BTLLC)minorStrategic or Co-development PartnerBTLLC (US subsidiary of Biopharma Group with 35 years of experience) offers lyophilisation process development, production, and troubleshooting operating under ISO 9001 & 13485 accreditation. The partnership enables Arete to offer cartridge design, microfluidics, wet chemistry, and lyophilization under one roof, with an open IP model where clients retain full ownership of their materials and data.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Arete Biosciences competitors and assessment

Company assessment

Direct peers

  • Cambridge Consultants: UK-based product development and engineering consultancy with deep MedTech and diagnostics practice. Comparable to Arete in offering multidisciplinary product development, including assay, instrumentation, and regulatory strategy for diagnostics clients.
  • Ximedica: US-based MedTech product development firm offering integrated design, engineering, and regulatory services for diagnostics and medical device companies. Closely matches Arete's full-lifecycle, cross-functional engagement model.
  • StarFish Medical: Canadian contract medical device design, development, and manufacturing firm. Directly comparable to Arete's integrated MedTech product development and industrial design services for IVD and diagnostics clients.
  • Planet Innovation: Australian MedTech product development and commercial manufacturing firm. Directly comparable integrated services model — design, engineering, regulatory, manufacturing — for diagnostics and medical device clients.

Emerging players

  • Bio-Techne: Life sciences tools and diagnostics company with growing services and assay development capabilities. Adjacent rather than direct overlap with Arete, but increasingly relevant as diagnostics developers seek integrated partners for assay and consumable development.
  • Bayonet Capital / Bayonet Life Sciences: Boutique life sciences consulting firm offering regulatory, quality, and clinical services to IVD and medical device companies. Partial overlap with Arete's Clinical, Quality & Regulatory practice, though smaller and less vertically integrated.

Broad incumbents

  • WuXi AppTec: Large global CRO/CDMO offering broad R&D, manufacturing, and regulatory services across biologics, small molecules, and MedTech. Competes with Arete's regulatory and clinical services for enterprise diagnostics clients but at much greater scale and scope.
  • Eurofins Scientific: Global testing, laboratory services, and product development firm with diagnostics and MedTech practice areas. Overlaps with Arete's clinical/biorepository and assay development services at greater scale and international reach.
  • ICON plc: Global CRO providing clinical trial, regulatory, and laboratory services to pharma, biotech, and MedTech. Competes with Arete's clinical and regulatory services, especially for larger enterprise programs.
  • Charles River Laboratories: Major CRO offering preclinical, clinical, and manufacturing services including diagnostics support. Overlaps with Arete's CRO practice but as part of a much broader portfolio serving large enterprise accounts.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Arete Biosciences social profiles

Digital presence

Arete Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arete Biosciences leadership team

Management profile

Number of profiles

Profiles5 records

Arete Biosciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arete Biosciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arete Biosciences

What does Arete Biosciences do?

Arete Biosciences is a multidisciplinary health technology product development firm that partners with diagnostics, MedTech, and life sciences companies to take products from concept through commercialization. Its core offering comprises four integrated service lines: Product Development (assay, consumable, and medical device engineering), Industrial Design (styling, ergonomics, human factors), Clinical, Quality & Regulatory (CRO services for clinical trials, quality systems, and FDA/IVDR regulatory strategy), and Arete Ventures (operational investment and startup incubation). Service delivery is supported by vertically integrated facilities including BSL-2 labs, lyophilization, prototyping, and an ISO 13485-compliant pilot line.

Is Arete Biosciences a public or private company?

Arete Biosciences is a private company. It is classified as unknown and is currently operating.

When was Arete Biosciences founded?

Arete Biosciences was founded in 2017. It employs 51 to 100 people.

Where is Arete Biosciences based?

Arete Biosciences is headquartered in Carlsbad, United States, in the North America region.

How does Arete Biosciences make money?

Three revenue lines are on record. Professional Services (CRO & Consulting) is the primary driver. The others are arete Ventures (Operational Investment) and certified Auditing Services.

Who are Arete Biosciences's main competitors?

Direct peers on record are Cambridge Consultants, Ximedica, StarFish Medical and Planet Innovation. Emerging players are Bio-Techne and Bayonet Capital / Bayonet Life Sciences. Broad incumbents are WuXi AppTec, Eurofins Scientific, ICON plc and Charles River Laboratories.

Does Arete Biosciences have an API?

No public API is recorded for Arete Biosciences.

What industry is Arete Biosciences in?

Arete Biosciences's product category is Medical Device & Diagnostics Product Development Services. Its primary akta.pro industry code is BPAHACAM, Innovation, Product & R&D Consulting, with a secondary code of HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewsfileGlucoGuard Receives Scope of Work (SOW) Proposal from Arete Bioscience for FDA Recommended Sleep StudyAmerican Diversified Holdings Corporation announced that its GlucoGuard product received a formal Scope of Work proposal from Arete Bioscience to conduct a sleep study required by the FDA for Breakthrough Device Designation approval. The FDA indicated all approval criteria were met but raised concerns about aspiration risk from glucose gel and the need to document glucose level changes before and after administration. The Medical Advisory Board submitted research studies from New Zealand and Ireland demonstrating positive results on both issues in neo-natal patients, and the sleep study is expected to initiate in the near term.NasdaqAmerican Diverisfied Holdings Corporation (ADHC) to Retain San Diego Based Bio Device Engineering Firm, Arete Bioscience, to Design GlucoGuard's Oral Diabetes Management DeviceAmerican Diversified Holdings Corporation (ADHC) has retained San Diego-based bio engineering firm Arete Bioscience to design its GlucoGuard nocturnal glucose monitoring and delivery device for diabetic patients, following an FDA Breakthrough Device directive. ADHC has also secured a non-dilutive funding commitment from a hedge fund specializing in public company financing, with funds to be provided in tranches based on a use-of-funds schedule. The GlucoGuard system, which integrates DEXCOM continuous glucose monitoring technology and artificial intelligence to automatically detect and treat hypoglycemia during sleep, is being developed in collaboration with Dr. Stephen Weber as advisor.Business Wire BlogIn Response to FDA LDT Final Rule, LISA Launches Crowdfunding Initiative for Clinical LaboratoriesLISA launched a crowdfunding initiative for CAP and COLA-accredited clinical laboratories to develop and gain FDA clearance for new diagnostic assays. The model shares financial and technical burdens, with support from partners like Argonaut and Arete Biosciences. The initiative aims to help labs navigate the FDA LDT final rule.